Related Experiment Videos
A Node-Adaptive Feature Fusion Network for Drug-Target Interaction Prediction Based on Multi-View Graphs
Lin Xie1, Hongmei Xu1, Pinglu Zhang1
1College of Electronic Engineering, Faculty of Information Science and Engineering, Ocean University of China, Qingdao 266404, China.
Biomolecules
|June 26, 2026
Summary
NAFF-DTI, a novel network, enhances drug-target interaction (DTI) prediction by adaptively fusing multi-view graph data. This approach improves accuracy and prioritizes potential drug candidates for repurposing.
Area of Science:
- Computational Biology
- Bioinformatics
- Drug Discovery
Background:
- Existing drug-target interaction (DTI) prediction methods struggle with sparse data, complex relationships, and imbalanced information.
- Accurate DTI prediction is crucial for drug discovery and repurposing.
Purpose of the Study:
- To develop a novel network, NAFF-DTI, for improved DTI prediction.
- To address challenges of sparse data and heterogeneous information in DTI prediction.
Main Methods:
- Proposed NAFF-DTI, a node-level adaptive feature fusion network based on multi-view graphs.
- Uniformly represented drug similarity, target similarity, and known DTIs as multiple relational views.
- Employed graph encoding, cross-view representation learning, cross-view feature discrepancy modeling, and adaptive fusion.
Main Results:
- NAFF-DTI achieved superior performance (AUC and AUPR) across five benchmark datasets.
- Demonstrated average relative improvements of 3.81% in AUC and 3.23% in AUPR over strongest baselines.
- Showcased enhanced utilization of multi-source information and stable predictions across data distributions.
Conclusions:
- NAFF-DTI offers a robust computational framework for DTI candidate prioritization.
- The model effectively generates hypotheses for drug repurposing.
- NAFF-DTI advances the field of computational drug discovery.
Related Concept Videos
Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Protein Networks
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...